Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial).
Ji-Jung Jung, Wonshik Han(Seoul National University), Sang Eun Nam(Konkuk University Medical Center), Seho Park(Seoul National University), Yoo Seok Kim(Chosun University), Jiwon Koh(Seoul National University Hospital), Sung Gwe Ahn(Yonsei University), Jai Min Ryu(Samsung Medical Center), Han‐Byoel Lee(Seoul National University Hospital), Tae-Kyung Yoo(Ulsan College), Jong-Ho Cheun(Seoul National University), Hee-Chul Shin(Seoul National University Bundang Hospital), Hyun Jo Youn(Jeonbuk National University Hospital), Woosung Lim(Ewha Womans University), Ku Sang Kim(Ajou University), Min Kyoon Kim(Chung-Ang University), Jeeyeon Lee(Northwestern University), Soo‐Yeon Kim(Seoul National University), Taewoo Kang(Pusan National University Hospital), Min Ho Park(Chonnam National University Hwasun Hospital)
Cited by 7
Related Papers
A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|Breast Cancer Research|2012|139
Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway
|Oncology Letters|2017|82
Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
|Oncotarget|2017|66
Genetic Polymorphisms of Ataxia Telangiectasia Mutated and Breast Cancer Risk
|Cancer Epidemiology Biomarkers & Prevention|2005|52
Recurrent fusion transcripts detected by whole‐transcriptome sequencing of 120 primary breast cancer samples
|Genes Chromosomes and Cancer|2015|49